Clinical Perspective: Treatment of Aggressive B Cell Lymphomas with FDA-Approved CAR-T Cell Therapies
Mark B. Leick, Marcela V. Maus, Matthew J. Frigault
Topics & Concepts
Chimeric antigen receptorMedicineImmunotherapyLymphomaCytokine release syndromeOncologyClinical trialDiseaseImmunologyCell therapyGenetic enhancementInternal medicineCellImmune systemBiologyGeneGeneticsBiochemistryCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design